Answers are grounded in this paper and cite their sources.
SenA alleviates OA progression by inhibiting NLRP3 signalling pathways. These findings provide an experimental basis for the clinical application of drugs in the treatment of OA.
No takes yet. Share an insight, caveat, or question.
Shao et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: